These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34546787)

  • 1. Sex Differences in Patients With Suspected Cardiac Sarcoidosis Assessed by Cardiovascular Magnetic Resonance Imaging.
    Kalra R; Malik S; Chen KA; Ogugua F; Athwal PSS; Elton AC; Velangi PS; Ismail MF; Chhikara S; Markowitz JS; Nijjar PS; von Wald L; Roukoz H; Bhargava M; Perlman D; Shenoy C
    Circ Arrhythm Electrophysiol; 2021 Sep; 14(9):e009966. PubMed ID: 34546787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the 2017 AHA/ACC/HRS Guideline Recommendations for Implantable Cardioverter-Defibrillator Implantation in Cardiac Sarcoidosis.
    Kazmirczak F; Chen KA; Adabag S; von Wald L; Roukoz H; Benditt DG; Okasha O; Farzaneh-Far A; Markowitz J; Nijjar PS; Velangi PS; Bhargava M; Perlman D; Duval S; Akçakaya M; Shenoy C
    Circ Arrhythm Electrophysiol; 2019 Sep; 12(9):e007488. PubMed ID: 31431050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of Late Gadolinium Enhancement by Cardiac Magnetic Resonance Among Patients With Suspected Cardiac Sarcoidosis Is Associated With Adverse Cardiovascular Prognosis: A Systematic Review and Meta-Analysis.
    Hulten E; Agarwal V; Cahill M; Cole G; Vita T; Parrish S; Bittencourt MS; Murthy VL; Kwong R; Di Carli MF; Blankstein R
    Circ Cardiovasc Imaging; 2016 Sep; 9(9):e005001. PubMed ID: 27621357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and prognostic significance of myocardial late gadolinium enhancement in patients with sarcoidosis without cardiac manifestation.
    Nagai T; Kohsaka S; Okuda S; Anzai T; Asano K; Fukuda K
    Chest; 2014 Oct; 146(4):1064-1072. PubMed ID: 24853830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right ventricular involvement and the extent of left ventricular enhancement with magnetic resonance predict adverse outcome in pulmonary sarcoidosis.
    Smedema JP; van Geuns RJ; Ector J; Heidbuchel H; Ainslie G; Crijns HJGM
    ESC Heart Fail; 2018 Feb; 5(1):157-171. PubMed ID: 28967698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic Resonance Imaging as a Predictor of Survival Free of Life-Threatening Arrhythmias and Transplantation in Cardiac Sarcoidosis.
    Ekström K; Lehtonen J; Hänninen H; Kandolin R; Kivistö S; Kupari M
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27139734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Right ventricular involvement is an important prognostic factor and risk stratification tool in suspected cardiac sarcoidosis: analysis by cardiac magnetic resonance imaging.
    Kagioka Y; Yasuda M; Okune M; Kakehi K; Kawamura T; Kobuke K; Miyazaki S; Iwanaga Y
    Clin Res Cardiol; 2020 Aug; 109(8):988-998. PubMed ID: 31872264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High mass (>18g) of late gadolinium enhancement on CMR imaging is associated with major cardiac events on long-term outcome in patients with biopsy-proven extracardiac sarcoidosis.
    Agoston-Coldea L; Kouaho S; Sacre K; Dossier A; Escoubet B; Chillon S; Laissy JP; Rouzet F; Kutty S; Extramiana F; Leenhardt A; Borie R; Crestani B; Ou P
    Int J Cardiol; 2016 Nov; 222():950-956. PubMed ID: 27526366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manifestations and Outcome of Cardiac Sarcoidosis and Idiopathic Giant Cell Myocarditis by 25-Year Nationwide Cohorts.
    Nordenswan HK; Lehtonen J; Ekström K; Räisänen-Sokolowski A; Mäyränpää MI; Vihinen T; Miettinen H; Kaikkonen K; Haataja P; Kerola T; Rissanen TT; Kokkonen J; Alatalo A; Pietilä-Effati P; Utriainen S; Kupari M
    J Am Heart Assoc; 2021 Mar; 10(6):e019415. PubMed ID: 33660520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right ventricular involvement in cardiac sarcoidosis demonstrated with cardiac magnetic resonance.
    Smedema JP; van Geuns RJ; Ainslie G; Ector J; Heidbuchel H; Crijns HJGM
    ESC Heart Fail; 2017 Nov; 4(4):535-544. PubMed ID: 29154434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators.
    Betensky BP; Tschabrunn CM; Zado ES; Goldberg LR; Marchlinski FE; Garcia FC; Cooper JM
    Heart Rhythm; 2012 Jun; 9(6):884-91. PubMed ID: 22338670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis.
    Ise T; Hasegawa T; Morita Y; Yamada N; Funada A; Takahama H; Amaki M; Kanzaki H; Okamura H; Kamakura S; Shimizu W; Anzai T; Kitakaze M
    Heart; 2014 Aug; 100(15):1165-72. PubMed ID: 24829369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis.
    Flamée L; Symons R; Degtiarova G; Dresselaers T; Gheysens O; Wuyts W; Van Cleemput J; Bogaert J
    Eur Radiol; 2020 Jul; 30(7):3702-3710. PubMed ID: 32166494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of definite or suspected isolated cardiac sarcoidosis: application of cardiac magnetic resonance imaging and 18F-Fluoro-2-deoxyglucose positron-emission tomography/computerized tomography.
    Tezuka D; Terashima M; Kato Y; Toriihara A; Hirasawa K; Sasaoka T; Yoshikawa S; Maejima Y; Ashikaga T; Suzuki J; Hirao K; Isobe M
    J Card Fail; 2015 Apr; 21(4):313-22. PubMed ID: 25512195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults.
    Kandolin R; Lehtonen J; Kupari M
    Circ Arrhythm Electrophysiol; 2011 Jun; 4(3):303-9. PubMed ID: 21427276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
    Wicks EC; Menezes LJ; Barnes A; Mohiddin SA; Sekhri N; Porter JC; Booth HL; Garrett E; Patel RS; Pavlou M; Groves AM; Elliott PM
    Eur Heart J Cardiovasc Imaging; 2018 Jul; 19(7):757-767. PubMed ID: 29319785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
    Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac sarcoidosis: the Christchurch experience.
    Adamson P; Melton I; O'Donnell J; MacDonald S; Crozier I
    Intern Med J; 2014 Jan; 44(1):70-6. PubMed ID: 24450522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and prognosis of patients with isolated cardiac sarcoidosis: Insights from the ILLUMINATE-CS study.
    Maeda D; Matsue Y; Dotare T; Sunayama T; Iso T; Yoshioka K; Nabeta T; Naruse Y; Kitai T; Taniguchi T; Tanaka H; Okumura T; Baba Y; Minamino T
    Eur J Heart Fail; 2024 Jan; 26(1):77-86. PubMed ID: 37823255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary Role of CMR to Conventional Screening in the Diagnosis and Prognosis of Cardiac Sarcoidosis.
    Kouranos V; Tzelepis GE; Rapti A; Mavrogeni S; Aggeli K; Douskou M; Prasad S; Koulouris N; Sfikakis P; Wells A; Gialafos E
    JACC Cardiovasc Imaging; 2017 Dec; 10(12):1437-1447. PubMed ID: 28330653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.